The Pharmacokinetic and Pharmacodynamic Impacts of Depot Medroxyprogesterone Acetate on HIV Pre-exposure Prophylaxis (PrEP)
Phase of Trial: Phase 0
Latest Information Update: 09 May 2018
Price : $35 *
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Medroxyprogesterone
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms DynamoPrEP
- 02 May 2018 Status changed from recruiting to completed.
- 15 Nov 2017 Status changed from not yet recruiting to recruiting.
- 04 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.